Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 03:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan. It's great to see everybody back in person again this year for a second year in a row. It's my pleasure this morning, though, to be introducing Bristol-Myers to again kick off the JPMorgan Healthcare Conference.

From the company, we have Chris Boerner who recently stepped into the CEO seat at Bristol, and looking forward to the conversation here, given all the updates and deal activity we've seen from the company recently.

So with that, Chris, Happy New Year. Thanks for joining us and look forward to the presentation.

Christopher S. Boerner - Bristol-Myers Squibb Company - CEO & Director

Thank you, Chris. So good morning, everyone. It is great to be kicking off the 2024 JPMorgan conference.

As Chris referenced, I have been in the CEO role now just over 2 months, and I am incredibly proud and excited to be taking over the leadership of this company with its over 150-year history of bringing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot